You are here

Article Text

Article menu
Download PDFPDF
DTB Select
MHRA: confusion over drug names

https://doi.org/10.1136/dtb.2018.3.0592

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Recent examples of medication errors arising from confusion between drug names (generic or brand) that look or sound similar have been highlighted by the Medicines and Healthcare products Regulatory Agency (MHRA).1 In 2010 and 2013, the MHRA issued safety alerts to remind healthcare professionals of the risks associated with confusion over drug names.2,3 The latest alert provides another reminder to …

    View Full Text